VRML News and Press, Aspira Womens Health From 03/26/20

VRML (VRML) Q4 2019 Results Conference Call March 26, 2020 04:30 PM ET Company Participants Valerie Palmieri - President and CEO Bob Beechey - CFO Chris Goulart - SVP, Commercial Operations Conference Call Participants Jeb Terry - Aberdeen Investment Management Jack Frase...

Conference Call scheduled for today, March 26 th  at 4:30 p.m. ET AUSTIN, Texas, March 26, 2020 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML), a bio-analytical based women’s health company focused on gynecologic disease, today reported its financial results for the fo...

AUSTIN, Texas, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML),  a bioanalytical-based women’s health company focused on gynecologic disease, today announced that management will participate in the 32 nd Annual Roth Conference taking place on March 15-17, 202...

MEDFORD, N.Y., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced President and Chief Executive Officer John Sperzel has resigned for another opportunity. The Chembio Board o...

AUSTIN, Texas, Jan. 02, 2020 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that management will participate in two investor events in San Francisco during the week of January 13, 202...

Study evaluates the differences in sensitivity of ovarian cancer risk detection between OVA1 ® Plus and CA125 Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease and Einstein Medical Center, the largest independent...

The following slide deck was published by Vermillion, Inc. in conjunction with this Read more ...

GenomeSmart, a Silicon Valley-based company delivering the first and only AI-powered genetic risk assessment and test recommendation platform to improve access to genetic testing, today announced a pilot program with ASPiRA LABS ® , a Vermillion company (Nasdaq: VRML), where GenomeBrain ...

AUSTIN, Texas, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that management will participate at the Piper Jaffray 31 st Annual Healthcare Conference, taking place Dec...

The NASDAQ Biotechnology Index (INDEXNASDAQ: NBI ) had a bit of a rocky week, but managed to stay in the green over the course of the trading period.  The index opened last Monday (November 11) at 3,459.2 points before reaching 3,492.46 points as of 1:33 p.m. EST on Friday (November 15)...